Category: Digital Content Distribution

Medical journal
Digital Content Distribution

Why relevance and impact are so important for HCPs

Making an impact attracts attention. Doesn’t it? Well, yes but only if the subject of the impact is relevant to the person being impacted. For it to resonate, it needs to be timed to perfection and the subject be of specific relevance to the recipient.

Read More »
T90 Perspective
Copyright Content Management

The omnichannel revolution

Omnichannel is more than just a buzzword. It is influencing the customer journey in pharma. Adding published scientific content to your omnichannel strategy can help add greater value for HCPs. Read the T90 perspective>>

Read More »
Personalised email
Copyright Content Management

Making it personal

What would make you more likely to respond? A dry, generic, mass-produced approach or one that addresses you personally and provides specific information on a topic of interest in an easy-to-digest format via a channel of your choice? We know what we’d prefer!

Read More »
Customer preferences
Copyright Content Management

Understanding your customers

Creating a complete picture of your customer preferences must surely rank high on the list of priorities for brand and marketing teams. Understanding what information your customer wants, engages with and values, will enable you to react quickly and build trust.

Read More »
Customer experience
Copyright Content Management

Creating the perfect experience

Customer experience should be front and centre for every service provider. Instilling trust enables companies to develop effective relationships with their customers. Pharma has the added challenge of time – with HCPs unable to spend hours meeting reps or reviewing data.

Read More »
Published scientific content
Copyright Content Management

The value of digital content continues to grow

The Veeva Pulse Field Trends Report covers 80% of HCP-rep interactions, making it the largest-ever analysis and provides valuable insights into the pharma industry and establishes a benchmark for HCP engagement across the globe. The latest report focuses on the increasing prevalence of digital content.

Read More »
HCP access
Copyright Content Management

Gaining better access to HCPs

HCPs have become more selective as to which pharma companies they will engage with. An average of 65% of accessible HCPs in Europe limit meetings to fewer than three companies, with greater restrictions in the UK. This presents pharma’s field teams with a challenge, so what can reps do to optimise the contact they do get?

Read More »
Omnichannel communication
Copyright Content Management

Mind the gap

There is a desire to leverage the data that omnichannel offers but the gap between aspiration and reality needs to close. Varying degrees of expertise within pharma means that the priority should be to utilise their existing agency relationships which offer a quick and cost-effective approach.

Read More »
Copyright compliance
Copyright Content Management

Managing compliance

With thousands of new regulatory guidelines issued every year, it’s easy for pharma to forget that something as simple as sharing copyright scientific content also requires a compliant approach. Keeping on top of these additional compliance requirements is a challenge, but there is a solution.

Read More »
Pharma web portal
Copyright Content Management

Portal pressure – making pharma portals work

According to an article in Pharmaphorum, pharma portals are underutilised by HCPs, with low engagement rates and reports of poor user experience. These portals are key to supporting the communication of product information. So given the importance of the information they provide, how can pharma make the portal experience more valuable for HCPs?

Read More »
Automation
Copyright Content Management

Automation is the way forward

An article in Pharmaphorum recently discussed why automating data capture is helping pharma optimise HCP engagement. A data-enriched approach enables pharma marketing teams to develop strategies which align with specific HCP preferences.

Read More »
First party data
Digital Content Distribution

The first-party data opportunity

The pharma industry has embraced the digital revolution and with that the opportunity to use more readily available data. However, effective digital engagement only works if first-party data (information a company collects directly from its customers and owns) is collected and subsequently used properly.

Read More »
Scroll to Top

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.